http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108373493-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J7-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00 |
| filingDate | 2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108373493-B |
| titleOfInvention | Pregnant steroid and its preparation method and application |
| abstract | The present invention relates to a kind of pregnant steroid, the structural formula of the compound is as follows: .The present invention also provides the preparation methods of the compound.The present invention it is found through experiment that: the compounds of this invention is to human leukemia cell (K562) and adriamycin-resistant human leukemia cell (K562/A02), human mouth epidermoid carcinoma (KB) and a variety of human tumor cell lines of resistance to vincristine human mouth epidermoid carcinoma (KB/VCR) show preferable cytotoxic activity, and furthermore the compound is better than sensitive strain to the cytotoxic activity of persister. |
| priorityDate | 2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.